At present, the prevalence of gout in China is between 1% and 3%, and the trend is increasing year by year. The onset of gout in China is showing a younger trend, and data from CRDC show that the average age of gout onset in China is currently 49.76 years. Gout is a classical and ancient rheumatic disease, which is a crystalline arthritis caused by the deposition of monosodium urate in the joints and is directly related to hyperuricemia caused by disorders of purine metabolism and/or reduced uric acid excretion, and belongs to the category of metabolic rheumatism. During acute attacks, patients often experience redness, swelling, pain and restricted movement in the joints, most typically in the first metatarsophalangeal joint of the foot, with pain peaking at night after drinking alcohol or eating seafood during the day, and even waking up in pain. Most gout patients have kidney involvement, especially chronic gout patients, and in severe cases, joint destruction and deformity, kidney function damage or even uremia, gout patients are often accompanied by hyperlipidemia, hypertension, diabetes, arteriosclerosis and coronary heart disease, which seriously endanger the quality of life of patients. However, at present, gout patients generally visit hospitals or rheumatology specialists late, and during the treatment process, most gout patients usually focus only on the treatment of acute attacks, ignoring intermittent uric acid reduction and prevention of complications, and have poor compliance with treatment, stopping the medication as soon as the joint inflammation is slightly relieved after a few days of taking the medication, and taking the medication again until the next attack, and treatment is intermittent. Data from the CRDC show that 45.2% of patients seek care for acute gout attacks, and the majority of patients do not seek care in between attacks. At the same time, some clinicians’ knowledge of gout needs to be updated, and some of them do not even understand the pathogenesis of gout and the correct diagnosis and treatment methods, and they do not know enough about the therapeutic drugs such as colchicine and uric acid-lowering drugs, the course of treatment and the goals of gout treatment, etc. A survey shows that 40.5% of doctors diagnose gout by elevated uric acid levels, and 61.9% believe that the blood uric acid level must be elevated during acute attacks, while The fact that some gout patients have normal blood uric acid levels in acute attacks is overlooked, resulting in missed diagnosis and misdiagnosis. It is worth pointing out that the presence of hyperuricemia in the interval without gout attack is not only the basis of gout attack, but also closely related to some other major chronic diseases, such as cardiovascular and cerebrovascular events, diabetes, etc., which are far more threatening to human health than the acute attack of gout. Therefore, the control of intermittent hyperuricemia in gout patients is of greater clinical importance, not only for the prevention of acute attacks of gout, but also for the reduction of cardiovascular and cerebrovascular accidents. The longer the duration of gout, the more gout stones in the body, the longer the duration of uric acid reduction. The longer the duration of gout and the more gout stones in the body, the longer the duration of uric acid reduction should be. “For men, uric acid should be controlled below 360umol/L, and for those with gout stones, it should be controlled below 300umol/L. Studies have shown that the direct benefits of meeting the blood uric acid standard are to reduce the number of acute attacks of gout, reduce uric acid crystals to dissolve gout stones, prevent joint damage, and reduce organ damage, and that long-term sustained uric acid standard can eventually cure some gout patients.